Publication
131I-labeled engineered hybrid cell membrane biomimetic nanocarrier targets gastric cancer and enhances radioimmunotherapy.
Chuanqiang Zhang, Hua Chen, Zheng Yuan, Anqi Dong, Shu Liu, Lin Hu, Kai Yang, Jin Zhou
Materials today. BioOct 1, 2026PMID 42602872doi:10.1016/j.mtbio.2026.103533 PMC13475372Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Oct 1, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20261001-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Achieving efficient radiolabeling and targeted delivery is essential to maximize therapeutic efficacy and reduce systemic toxicity. Herein, we report a novel radionuclide-delivery platform based on hybrid membranes derived from fusing liposome with statherin engineered macrophage membranes and…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Gastric Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.